Capsida Biotherapeutics
PrivateLast Round
Strategic
Feb 23, 2023
Total Funding Raised
$185M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Capsida Biotherapeutics is a biotechnology company that develops targeted gene therapies aimed at treating debilitating and life-threatening genetic disorders through an advanced adeno-associated virus (AAV) engineering platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Capsida Biotherapeutics Comparables
Compare Capsida Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latus Bio | 89% | |
| Coave Therapeutics | 85% | |
| Apertura Gene Therapy | 85% | |
Capsida Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Feb 23, 2023 | ||||
| Strategic | Jan 4, 2023 | ||||
| Series A | Apr 29, 2021 |
Capsida Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village BioPartners | Series A |
| Versant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 77% MoM.
- May 14, 2025
Presented at the 28th Annual Meeting of the American Society of Gene & Cell Therapy.
Capsida Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Capsida Biotherapeutics's valuation, stock price, and market status.